Movement Alert｜Duality Biotherapeutics-B Falls 5.38% in Regular Trading, Trading at 210.8 HKD

Market Focus

May 28

On May 28, Duality Biotherapeutics-B fell 5.38% in regular trading, trading at 210.8 HKD/share, with trading volume of 68.3979 million HKD.

Within the Biotechnology sector where Duality Biotherapeutics-B belongs, the overall sector is under pressure. Among individual stocks, INNOVENT BIO down 2.22%, AKESO down 3.04%, 3SBIO down 6.06%, PEGBIO CO-B down 2.83%, BEIGENE down 2.49%.

Duality Biotherapeutics is a clinical-stage biopharmaceutical investment holding company dedicated to developing antibody-drug conjugate (ADC) innovative therapies for cancer and autoimmune diseases. Its key drug candidates include DB-1303/BNT323 and DB-1311/BNT324, targeting multiple solid tumors including endometrial cancer, breast cancer, small cell lung cancer, and castration-resistant prostate cancer.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1132277106"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1132277106\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1132277106?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-28 13:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1132277106","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Duality Biotherapeutics-B Falls 5.38% in Regular Trading, Trading at 210.8 HKD","media":"Market Focus","content":"<p><p>On May 28, Duality Biotherapeutics-B fell 5.38% in regular trading, trading at 210.8 HKD/share, with trading volume of 68.3979 million HKD.</p><p>Within the Biotechnology sector where Duality Biotherapeutics-B belongs, the overall sector is under pressure. Among individual stocks, INNOVENT BIO down 2.22%, AKESO down 3.04%, 3SBIO down 6.06%, PEGBIO CO-B down 2.83%, BEIGENE down 2.49%.</p><p>Duality Biotherapeutics is a clinical-stage biopharmaceutical investment holding company dedicated to developing antibody-drug conjugate (ADC) innovative therapies for cancer and autoimmune diseases. Its key drug candidates include DB-1303/BNT323 and DB-1311/BNT324, targeting multiple solid tumors including endometrial cancer, breast cancer, small cell lung cancer, and castration-resistant prostate cancer.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Duality Biotherapeutics-B Falls 5.38% in Regular Trading, Trading at 210.8 HKD</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Duality Biotherapeutics-B Falls 5.38% in Regular Trading, Trading at 210.8 HKD\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-05-28 13:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On May 28, Duality Biotherapeutics-B fell 5.38% in regular trading, trading at 210.8 HKD/share, with trading volume of 68.3979 million HKD.</p><p>Within the Biotechnology sector where Duality Biotherapeutics-B belongs, the overall sector is under pressure. Among individual stocks, INNOVENT BIO down 2.22%, AKESO down 3.04%, 3SBIO down 6.06%, PEGBIO CO-B down 2.83%, BEIGENE down 2.49%.</p><p>Duality Biotherapeutics is a clinical-stage biopharmaceutical investment holding company dedicated to developing antibody-drug conjugate (ADC) innovative therapies for cancer and autoimmune diseases. Its key drug candidates include DB-1303/BNT323 and DB-1311/BNT324, targeting multiple solid tumors including endometrial cancer, breast cancer, small cell lung cancer, and castration-resistant prostate cancer.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09606","symbol_name":"映恩生物-B","start_time":0,"source_url":"","article_id":"1132277106","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1132277106","pubTimestamp":1779944598,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On May 28, Duality Biotherapeutics-B fell 5.38% in regular trading, trading at 210.8 HKD/share, with trading volume of 68.3979 million HKD.Within the Biotechnology sector where Duality...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09606":"映恩生物-B"},"translate_title":"动静|Duality Biotherapeutics-B在常规交易中跌5.38%，收报210.8港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09606":1},"content_text":"On May 28, Duality Biotherapeutics-B fell 5.38% in regular trading, trading at 210.8 HKD/share, with trading volume of 68.3979 million HKD.Within the Biotechnology sector where Duality Biotherapeutics-B belongs, the overall sector is under pressure. Among individual stocks, INNOVENT BIO down 2.22%, AKESO down 3.04%, 3SBIO down 6.06%, PEGBIO CO-B down 2.83%, BEIGENE down 2.49%.Duality Biotherapeutics is a clinical-stage biopharmaceutical investment holding company dedicated to developing antibody-drug conjugate (ADC) innovative therapies for cancer and autoimmune diseases. Its key drug candidates include DB-1303/BNT323 and DB-1311/BNT324, targeting multiple solid tumors including endometrial cancer, breast cancer, small cell lung cancer, and castration-resistant prostate cancer.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}